Hepatology

Top Story

Zydus completes enrollment in trial of Lipaglyn for NAFLD, NASH

June 26, 2019

Emricasan fails to meet primary endpoint in NASH-cirrhosis trial

June 26, 2019
Emricasan did not meet its either of its primary phase 2b trial endpoints in patients with nonalcoholic steatohepatitis-related decompensated cirrhosis, according to a…
In the Journals

‘Easy to follow’ advance directives more likely to be used

June 26, 2019
Both clinicians and patients more often utilized advance directives that were more “readable, understandable, appealing and usable,” according to findings…
FDA News

FDA issues new warnings for illegally selling kratom-based products

June 25, 2019
The FDA announced today that it issued warning letters to Cali Botanicals of Folsom, California, and Kratom NC of Wilmington, North Carolina, for “illegally…
In the Journals

Sovaldi with ribavirin safe, effective for children aged 3 years to 12 years

June 25, 2019
Treatment with Sovaldi and ribavirin was well-tolerated and highly effective in children aged 3 years to less than 12 years in pediatric patients with hepatitis C…
More Headlines »
CME

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »
GI Bookshelf

Question 20: A 58-Year-Old Female Underwent A Screening Colonoscopy That Showed A 2.5-Cm Flat Polyp In The Proximal Ascending Colon. I Tattooed The Area And Biopsied The Polyp, Which Was Initially Reported As Hyperplastic. What Should I Do?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Resource Centers
International Liver Congress

International Liver Congress

Video
Meeting News

VIDEO: Genfit promotes NASH awareness as equally important as therapy

April 30, 2019
More »
Current Issues Current Issues
View the Current Issue
HCV Next